All
Climbing Kilimanjaro for Multiple Myeloma Research Inspired More Than Just Donations
February 13th 2016"There are not a whole lot of patients that are able to do something like this, so we were doing it for them as well," says Chuck Wakefield. "It meant so much to them to have their names on the banner."
New Therapy Shows Early Promise, Continues to Progress in Triple-Negative Breast Cancer
February 8th 2016The designation, which will expedite the development and review of sacituzumab govitecan in TNBC, is based on a phase 2 trial in which the therapy induced a response rate of 31 percent in heavily pretreated patients with metastatic TNBC.